rs34120190

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_001378373.1(MBL2):​c.132C>T​(p.Asn44Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,613,864 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 19 hom. )

Consequence

MBL2
NM_001378373.1 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -2.09

Publications

3 publications found
Variant links:
Genes affected
MBL2 (HGNC:6922): (mannose binding lectin 2) This gene encodes the soluble mannose-binding lectin or mannose-binding protein found in serum. The protein encoded belongs to the collectin family and is an important element in the innate immune system. The protein recognizes and binds to mannose and N-acetylglucosamine on many microorganisms, including bacteria, yeast, and viruses including influenza virus, HIV and SARS-CoV. This binding activates the classical complement pathway. Deficiencies of this gene have been associated with susceptibility to autoimmune and infectious diseases. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-52771504-G-A is Benign according to our data. Variant chr10-52771504-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 403073.
BP7
Synonymous conserved (PhyloP=-2.09 with no splicing effect.
BS2
High AC in GnomAd4 at 168 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MBL2NM_001378373.1 linkc.132C>T p.Asn44Asn synonymous_variant Exon 2 of 5 ENST00000674931.1 NP_001365302.1
MBL2NM_000242.3 linkc.132C>T p.Asn44Asn synonymous_variant Exon 1 of 4 NP_000233.1 P11226
MBL2NM_001378374.1 linkc.132C>T p.Asn44Asn synonymous_variant Exon 2 of 5 NP_001365303.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MBL2ENST00000674931.1 linkc.132C>T p.Asn44Asn synonymous_variant Exon 2 of 5 NM_001378373.1 ENSP00000502789.1 P11226
MBL2ENST00000373968.3 linkc.132C>T p.Asn44Asn synonymous_variant Exon 1 of 4 1 ENSP00000363079.3 P11226
MBL2ENST00000675947.1 linkc.132C>T p.Asn44Asn synonymous_variant Exon 2 of 5 ENSP00000502615.1 P11226

Frequencies

GnomAD3 genomes
AF:
0.00110
AC:
167
AN:
152108
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000750
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00208
AC:
523
AN:
251182
AF XY:
0.00259
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.0120
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000820
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.00131
AC:
1911
AN:
1461638
Hom.:
19
Cov.:
32
AF XY:
0.00153
AC XY:
1113
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33472
American (AMR)
AF:
0.00150
AC:
67
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0119
AC:
310
AN:
26112
East Asian (EAS)
AF:
0.000630
AC:
25
AN:
39700
South Asian (SAS)
AF:
0.00775
AC:
668
AN:
86246
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53420
Middle Eastern (MID)
AF:
0.0139
AC:
80
AN:
5760
European-Non Finnish (NFE)
AF:
0.000553
AC:
615
AN:
1111834
Other (OTH)
AF:
0.00222
AC:
134
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
104
208
313
417
521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00110
AC:
168
AN:
152226
Hom.:
3
Cov.:
32
AF XY:
0.00117
AC XY:
87
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41538
American (AMR)
AF:
0.000850
AC:
13
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00642
AC:
31
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000750
AC:
51
AN:
68006
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00168
Hom.:
0
Bravo
AF:
0.000979
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.00202
EpiControl
AF:
0.00119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 27, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MBL2: BP4, BP7 -

Mannose-binding lectin deficiency Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Silent variant not in splice consensus -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.40
DANN
Benign
0.63
PhyloP100
-2.1
PromoterAI
-0.029
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34120190; hg19: chr10-54531264; COSMIC: COSV64759430; API